Predicting response and survival in chemotherapy-treated triple-negative breast cancerAleix Prat, Emilio Alba, Cheng Fan et al.|British Journal of Cancer|2014Cited by 113
Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103Chaitra S. Ujjani, Bruce D. Cheson, Sin‐Ho Jung et al.|Blood|2016Cited by 59